Entropy Neurodynamics

Q: And finally, in your view how do you see the remainder of the trial playing out? youtu.be/GJf5lxmaJb0 #psychedelics $ENP #ASX #biotech

Q: IV #psilocin vs oral #psilocybin — what benefits have you seen in patient acceptance, and how meaningful is this shift for consistency, safety & real-world deployment? youtu.be/GJf5lxmaJb0 $ENP #psychedelics #biotech

Q: As Principal Investigator of $ENP TRP-8803, how important is delivering a controlled, reproducible #psychedelic experience for scalable, regulator-friendly therapies? youtu.be/GJf5lxmaJb0 #biotech #ASX

Q: You’ve spent decades studying psychiatric neurobiology — what makes #psychedelics scientifically compelling, and how do they differ from traditional mental health treatments? youtu.be/GJf5lxmaJb0 $ENP #ASX #biotech

REMINDER: Join $ENP investor #webinar at 10:30am AEST (8:30am AWST) Wed 6 May 2026, hosted by CEO Jason Carroll, discussing TRP-8803 clinical progress, followed by live Q&A. Don't forget to register: us02web.zoom.us/webinar/regist… #psychedelic #biotech

ICYMI: $ENP files US provisional patent (No. 64/055,765) for TRP-8803 IBS program, supported by Phase 2a data showing a 75% response rate in treatment-resistant IBS vs 17–44% standard therapies, strengthening US IP and partnering strategy. cdn-api.markitdigital.com/apiman-gateway… #psychedelic

Q: And finally, in your view how do you see the remainder of the trial playing out? youtu.be/GJf5lxmaJb0 #psychedelics $ENP #ASX #biotech

Q: IV #psilocin vs oral #psilocybin — what benefits have you seen in patient acceptance, and how meaningful is this shift for consistency, safety & real-world deployment? youtu.be/GJf5lxmaJb0 $ENP #psychedelics #biotech

Q: As Principal Investigator of $ENP TRP-8803, how important is delivering a controlled, reproducible #psychedelic experience for scalable, regulator-friendly therapies? youtu.be/GJf5lxmaJb0 #biotech #ASX

Q: You’ve spent decades studying psychiatric neurobiology — what makes #psychedelics scientifically compelling, and how do they differ from traditional mental health treatments? youtu.be/GJf5lxmaJb0 $ENP #ASX #biotech

Join $ENP investor #webinar at 10:30am AEST (8:30am AWST) Wed 6 May 2026, hosted by CEO Jason Carroll, discussing TRP-8803 clinical progress, followed by live Q&A. Don't forget to register: us02web.zoom.us/webinar/regist… #psychedelic #biotech

$ENP files US provisional patent (No. 64/055,765) for TRP-8803 IBS program, supported by Phase 2a data showing a 75% response rate in treatment-resistant IBS vs 17–44% standard therapies, strengthening US IP and partnering strategy. cdn-api.markitdigital.com/apiman-gateway… #psychedelic

ICYMI: Entropy Neurodynamics (#ASX: $ENP) reports a 75% response rate in treatment-resistant IBS in Phase 2a TRP-8802 trial, with results presented at DDW 2026, supporting a gut-brain mechanism and advancing TRP-8803 development. Read more: cdn-api.markitdigital.com/apiman-gateway…

Entropy Neurodynamics (#ASX: $ENP) reports a 75% response rate in treatment-resistant IBS in Phase 2a TRP-8802 trial, with results presented at DDW 2026, supporting a gut-brain mechanism and advancing TRP-8803 development. Read more: cdn-api.markitdigital.com/apiman-gateway…

Q: A key US theme is safe, scalable clinical delivery. With $ENP’s focus on precision IV dosing and controlled experiences, is your platform directly aligned with regulator priorities? youtu.be/h2j1jSGXqiM #psychedelic #health #biotech

Q: #Psychedelic #stocks have rallied on US policy momentum. What are the near-term catalysts for $ENP to show it can capitalise on these regulatory tailwinds? youtu.be/h2j1jSGXqiM #health #biotech

ICYMI via @InvestorStream_ Q: The US is fast-tracking #psychedelic therapies via FDA reform, with timelines shrinking from months to weeks. How does this shift your view on TRP-8803’s global pathway, and where does $ENP fit? youtu.be/h2j1jSGXqiM #biotech #health #stocks

ICYMI: Entropy Neurodynamics (#ASX: $ENP) March Quarterly Report highlights early TRP-8803 BED validation, Phase 2 progress, ~80% reduction in binge eating episodes from TRP-8802, patent to 2042 and $9.1m cash for upcoming trials. Read more: cdn-api.markitdigital.com/apiman-gateway…

Q: #Psychedelic #stocks have rallied on US policy momentum. What are the near-term catalysts for $ENP to show it can capitalise on these regulatory tailwinds? youtu.be/h2j1jSGXqiM #health #biotech

Q: A key US theme is safe, scalable clinical delivery. With @Entropy_Neuro $ENP ’s focus on precision IV dosing and controlled experiences, is your platform directly aligned with regulator priorities? youtu.be/h2j1jSGXqiM #psychedelic #health #biotech